Yeh, W-H. et al. Sci. Transl. Med. 12, eaay9101 (2020)
Genetic defects are a major cause of hearing loss (HL) in newborns. No curative treatments are available for genetic HL, but gene therapy-based strategies that replace an absent gene product or silence a pathological allele have shown promising results in mouse models.
A study describes a new base-editing approach aimed at correcting a point mutation in Tmc1 that causes deafness in Baringo mice. Adeno-associated virus (AAV) delivery of a cytosine base editor and guide RNA into the inner ears of Baringo mice at postnatal day 1 successfully corrected the Tmc1 mutation and partially rescued auditory function, thereby demonstrating the potential of base editing as a treatment for HL caused by recessive loss-of-function point mutations.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Bras, A. Restoring hearing in mice. Lab Anim 49, 220 (2020). https://doi.org/10.1038/s41684-020-0605-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-020-0605-2